XBiotech Inc.

XBIT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$38,531-$24,557-$32,900-$17,414
Dep. & Amort.$1,745$1,744$2,614$2,648
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,753$0$5,062$4,463
Change in WC-$1,459$2,719$7,600$79,748
Other Non-Cash$5,529$1,369$2,800$0
Operating Cash Flow-$30,963-$18,725-$14,824$69,445
Investing Activities
PP&E Inv.-$1,304-$362-$585-$3,525
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$63,307$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$61,859$0$0
Investing Cash Flow-$1,304$61,497-$63,892-$3,525
Financing Activities
Debt Repay.$10,250$0$0$0
Stock Issued$0$5$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0-$75,003
Other Fin. Act.$200-$14$0$7,995
Financing Cash Flow$10,450-$9$0-$67,008
Forex Effect-$5,529-$46-$961$705
Net Chg. in Cash-$27,346$42,717-$79,677-$383
Supplemental Information
Beg. Cash$200,023$157,306$236,983$237,366
End Cash$172,677$200,023$157,306$236,983
Free Cash Flow-$32,267-$19,087-$15,409$65,920